金吾财讯 | 雅培(ABT)盘前公布2024年第四季度业绩。营收为109.74亿美元，同比增长7.15%，预期为110.1亿美元；每股收益为5.27美元，预期为1.05美元。虽然公司医疗器械部门的销售额超出预期，但其营养、诊断和仿制药部门的销售额低于预期。公司预计第一季度调整后每股利润为 1.05 美元至 1.09 美元，低于分析师平均预期的 1.11 美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.